ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells.

Zhi-hua Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.